Approval · Notice of Compliance 9876 · 2008
OVIDREL: Notice of Compliance 9876
Issued November 7, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9876
- Date
- November 7, 2008
- Company
- Emd Serono Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Gonadotropin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OVIDREL | Not yet assigned | — |
Medicinal ingredients
- CHORIOGONADOTROPIN ALFA 250 MCG per 0.5ML